When does the Alimta (pemetrexed) patent expire?
The provided information does not include any patent filings or patent/expiration dates for Alimta (pemetrexed). Without those specific patent records (e.g., patent numbers, territories like the US/EU/UK, and whether you mean drug substance vs. formulation vs. method-of-use), it isn’t possible to state an accurate expiration date.
Are there different expiration dates depending on where you live (US vs EU vs UK)?
Yes. Patent expiration is territory-specific. Even when a single company owns multiple patents around the same medicine, each patent can expire on different dates depending on filing/priority and local patent term rules. To give a correct date, you would need the country/region and the particular patent(s) covering Alimta in that region.
What matters more for launch timing: “patent expiry” or “market exclusivity”?
For drugs like Alimta, market entry timing can be affected by more than just patent term, including exclusivity protections that vary by country and by regulatory pathway (for example, the ability to rely on existing clinical data and protections tied to the original approval). Exact timing requires the regulatory jurisdiction and the specific exclusivity provisions that apply.
How can you get the exact expiration date you need?
If you share any of the following, I can help pinpoint the right expiration timing from the relevant patent/exclusivity records (including when generics or biosimilars could enter, if applicable):
- The country/region (US, EU, UK, etc.)
- Whether you mean the original Alimta (brand) or a specific generic/manufacturer in that region
- Any known patent numbers or the filing year
- Whether you care about drug substance, formulation, or specific uses (method-of-use)
Sources
No sources were provided with the question, and no patent data or jurisdiction details were included to support an Alimta patent expiration date.